新生血管性眼病的治疗进展  

Progress in the treatment of ocular neovascular diseases

作　　者：陈泽丽[1] 祝丽娜[1] 余梓逵[1] 柳林[1] 

机构地区：[1]上海交通大学医学院附属仁济医院眼科,上海200127

出　　处：《中华老年多器官疾病杂志》2015年第1期27-32,共6页Chinese Journal of Multiple Organ Diseases in the Elderly

基　　金：上海市科学技术委员会科研计划项目（124119a9500）;上海市浦东新区卫生局卫生（计生）科技项目（PW2013D-1）;上海申康医院发展中心郊区三级医院临床能力建设项目（SHDC12013905）

摘　　要：随着人口老龄化和生活质量的提高，以年龄相关性黄斑变性及糖尿病性视网膜病变为主的新生血管性眼病正日益成为影响患者生活质量的主要因素。新生血管性眼病以新生血管形成为主要病理表现，病因复杂、机制多样、预后不佳是其主要特征。近年来激光、抗VEGF药物及手术等多种药物和治疗方法的不断涌现与改进，为该类疾病的治疗带来更多更好的疗法。本文就这一系列新生血管性眼病的治疗进展予以综述。With population ageing and improvement of life quality, ocular neovascular disease, mainly manifesting as age-related macular degeneration and diabetic retinopathy, gradually becomes a major factor affecting the quality of life in the patients. Neovascularization is its main pathological manifestation. What＇s more, the disease is characterized by its complicated causes, various mechanisms, and poor prognosis. In recent years, there are a variety of drugs and treatment methods emerged and improved, such as laser therapy, anti-VEGF drugs, and surgical treatment, which have provided more and better therapies to treat such diseases. This article reviewed the advances in the treatment of the ocular neovascular diseases.

关 键 词：新生血管性眼病 抗VEGF 激光 光动力疗法 

分 类 号：R77[医药卫生—眼科] R349.51[医药卫生—临床医学]